Scynexis Net Income
| SCYX Stock | USD 0.80 0.01 1.23% |
As of the 11th of February 2026, Scynexis has the Semi Deviation of 2.11, coefficient of variation of 875.55, and Risk Adjusted Performance of 0.0994. In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Scynexis, as well as the relationship between them.
Scynexis Total Revenue |
|
Gross Profit | Market Capitalization | Enterprise Value Revenue 0.4358 | Revenue | Earnings Share (0.51) |
| Last Reported | Projected for Next Year | ||
| Net Loss | -24.5 M | -25.7 M | |
| Net Loss | -24.5 M | -25.7 M | |
| Net Loss | -29.6 M | -31.1 M | |
| Net Loss | (0.39) | (0.41) | |
| Net Income Per E B T | 0.91 | 0.72 |
Scynexis | Net Income | Build AI portfolio with Scynexis Stock |
The evolution of Net Income for Scynexis provides essential context for understanding the company's financial health trajectory. By analyzing this metric's behavior over time, investors can assess whether recent trends align with long-term patterns, and how Scynexis compares to historical norms and industry peers.
Latest Scynexis' Net Income Growth Pattern
Below is the plot of the Net Income of Scynexis over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Scynexis financial statement analysis. It represents the amount of money remaining after all of Scynexis operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Scynexis' Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Scynexis' overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported (21.29 M) | 10 Years Trend |
|
Net Income |
| Timeline |
Scynexis Net Income Regression Statistics
| Arithmetic Mean | (22,251,145) | |
| Geometric Mean | 24,168,415 | |
| Coefficient Of Variation | (127.28) | |
| Mean Deviation | 17,691,531 | |
| Median | (25,060,000) | |
| Standard Deviation | 28,321,974 | |
| Sample Variance | 802.1T | |
| Range | 129.8M | |
| R-Value | (0.04) | |
| Mean Square Error | 854.3T | |
| R-Squared | 0 | |
| Significance | 0.88 | |
| Slope | (221,281) | |
| Total Sum of Squares | 12834.1T |
Scynexis Net Income History
Other Fundumenentals of Scynexis
| Net Income From Continuing Ops | ||
| Net Income Applicable To Common Shares | ||
| Net Income Per Share | ||
| Net Income Per E B T |
Scynexis Net Income component correlations
Scynexis Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for Scynexis is extremely important. It helps to project a fair market value of Scynexis Stock properly, considering its historical fundamentals such as Net Income. Since Scynexis' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Scynexis' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Scynexis' interrelated accounts and indicators.
Click cells to compare fundamentals
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Scynexis. If investors know Scynexis will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Scynexis assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Earnings Share (0.51) | Revenue Per Share | Quarterly Revenue Growth (0.49) | Return On Assets | Return On Equity |
The market value of Scynexis is measured differently than its book value, which is the value of Scynexis that is recorded on the company's balance sheet. Investors also form their own opinion of Scynexis' value that differs from its market value or its book value, called intrinsic value, which is Scynexis' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Scynexis' market value can be influenced by many factors that don't directly affect Scynexis' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Scynexis' value and its price as these two are different measures arrived at by different means. Investors typically determine if Scynexis is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Meanwhile, Scynexis' quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
Scynexis 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Scynexis' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Scynexis.
| 11/13/2025 |
| 02/11/2026 |
If you would invest 0.00 in Scynexis on November 13, 2025 and sell it all today you would earn a total of 0.00 from holding Scynexis or generate 0.0% return on investment in Scynexis over 90 days. Scynexis is related to or competes with Talphera, Cosmos Health, Cadrenal Therapeutics, Exicure, Klotho Neurosciences, Collplant Biotechnologies, and Nexalin Technology. SCYNEXIS, Inc., a biotechnology company, develops products for the treatment fungal infections in the United States More
Scynexis Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Scynexis' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Scynexis upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 2.88 | |||
| Information Ratio | 0.091 | |||
| Maximum Drawdown | 22.21 | |||
| Value At Risk | (4.17) | |||
| Potential Upside | 8.0 |
Scynexis Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Scynexis' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Scynexis' standard deviation. In reality, there are many statistical measures that can use Scynexis historical prices to predict the future Scynexis' volatility.| Risk Adjusted Performance | 0.0994 | |||
| Jensen Alpha | 0.3976 | |||
| Total Risk Alpha | 0.0339 | |||
| Sortino Ratio | 0.1262 | |||
| Treynor Ratio | 0.7569 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Scynexis' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Scynexis February 11, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0994 | |||
| Market Risk Adjusted Performance | 0.7669 | |||
| Mean Deviation | 2.68 | |||
| Semi Deviation | 2.11 | |||
| Downside Deviation | 2.88 | |||
| Coefficient Of Variation | 875.55 | |||
| Standard Deviation | 4.0 | |||
| Variance | 15.96 | |||
| Information Ratio | 0.091 | |||
| Jensen Alpha | 0.3976 | |||
| Total Risk Alpha | 0.0339 | |||
| Sortino Ratio | 0.1262 | |||
| Treynor Ratio | 0.7569 | |||
| Maximum Drawdown | 22.21 | |||
| Value At Risk | (4.17) | |||
| Potential Upside | 8.0 | |||
| Downside Variance | 8.3 | |||
| Semi Variance | 4.44 | |||
| Expected Short fall | (4.68) | |||
| Skewness | 1.9 | |||
| Kurtosis | 5.07 |
Scynexis Backtested Returns
Scynexis appears to be dangerous, given 3 months investment horizon. Scynexis owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.14, which indicates the firm had a 0.14 % return per unit of risk over the last 3 months. By inspecting Scynexis' technical indicators, you can evaluate if the expected return of 0.58% is justified by implied risk. Please review Scynexis' Semi Deviation of 2.11, coefficient of variation of 875.55, and Risk Adjusted Performance of 0.0994 to confirm if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Scynexis holds a performance score of 11. The entity has a beta of 0.59, which indicates possible diversification benefits within a given portfolio. As returns on the market increase, Scynexis' returns are expected to increase less than the market. However, during the bear market, the loss of holding Scynexis is expected to be smaller as well. Please check Scynexis' downside variance and the relationship between the skewness and day typical price , to make a quick decision on whether Scynexis' existing price patterns will revert.
Auto-correlation | -0.12 |
Insignificant reverse predictability
Scynexis has insignificant reverse predictability. Overlapping area represents the amount of predictability between Scynexis time series from 13th of November 2025 to 28th of December 2025 and 28th of December 2025 to 11th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Scynexis price movement. The serial correlation of -0.12 indicates that less than 12.0% of current Scynexis price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.12 | |
| Spearman Rank Test | -0.08 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Scynexis Accumulated Other Comprehensive Income
Accumulated Other Comprehensive Income |
|
Based on the recorded statements, Scynexis reported net income of (21.29 Million). This is 106.24% lower than that of the Pharmaceuticals sector and significantly lower than that of the Health Care industry. The net income for all United States stocks is 103.73% higher than that of the company.
Scynexis Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Scynexis' direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Scynexis could also be used in its relative valuation, which is a method of valuing Scynexis by comparing valuation metrics of similar companies.Scynexis is currently under evaluation in net income category among its peers.
Scynexis Current Valuation Drivers
We derive many important indicators used in calculating different scores of Scynexis from analyzing Scynexis' financial statements. These drivers represent accounts that assess Scynexis' ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Scynexis' important valuation drivers and their relationship over time.
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 (projected) | ||
| Market Cap | 160.9M | 66.5M | 106.7M | 58.7M | 52.8M | 58.3M | |
| Enterprise Value | 100.1M | 69.3M | 87.7M | 58.9M | 53.0M | 38.6M |
Scynexis Institutional Holders
Institutional Holdings refers to the ownership stake in Scynexis that is held by large financial organizations, pension funds or endowments. Institutions may hold large blocks of Scynexis' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Scynexis' value.| Shares | State Street Corp | 2025-06-30 | 120.7 K | Wealth Effects Llc | 2025-06-30 | 99.5 K | Northern Trust Corp | 2025-06-30 | 82.7 K | Nierenberg Investment Management Co | 2025-06-30 | 75.6 K | Ubs Group Ag | 2025-06-30 | 63.7 K | Lpl Financial Corp | 2025-06-30 | 63.4 K | Susquehanna International Group, Llp | 2025-06-30 | 58.7 K | Gsa Capital Partners Llp | 2025-06-30 | 53.5 K | Jane Street Group Llc | 2025-06-30 | 39.5 K | Federated Hermes Inc | 2025-06-30 | 2.9 M | Kingdon Capital Management Llc | 2025-06-30 | 2.2 M |
Scynexis Fundamentals
| Return On Equity | -0.53 | ||||
| Return On Asset | -0.29 | ||||
| Operating Margin | (25.16) % | ||||
| Current Valuation | (3.39 M) | ||||
| Shares Outstanding | 41.97 M | ||||
| Shares Owned By Insiders | 3.71 % | ||||
| Shares Owned By Institutions | 32.60 % | ||||
| Number Of Shares Shorted | 1.15 M | ||||
| Price To Earning | (1.90) X | ||||
| Price To Book | 0.89 X | ||||
| Price To Sales | 10.74 X | ||||
| Revenue | 3.75 M | ||||
| Gross Profit | 2.93 M | ||||
| EBITDA | (18.58 M) | ||||
| Net Income | (21.29 M) | ||||
| Cash And Equivalents | 96.09 M | ||||
| Cash Per Share | 2.94 X | ||||
| Total Debt | 16.27 M | ||||
| Debt To Equity | 2.80 % | ||||
| Current Ratio | 7.26 X | ||||
| Book Value Per Share | 0.87 X | ||||
| Cash Flow From Operations | (24.01 M) | ||||
| Short Ratio | 2.92 X | ||||
| Earnings Per Share | (0.51) X | ||||
| Target Price | 3.67 | ||||
| Number Of Employees | 28 | ||||
| Beta | 1.34 | ||||
| Market Capitalization | 31.49 M | ||||
| Total Asset | 90.64 M | ||||
| Retained Earnings | (376.54 M) | ||||
| Working Capital | 48.08 M | ||||
| Current Asset | 48.44 M | ||||
| Current Liabilities | 6.66 M | ||||
| Net Asset | 90.64 M |
About Scynexis Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Scynexis's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Scynexis using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Scynexis based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Scynexis Stock Analysis
When running Scynexis' price analysis, check to measure Scynexis' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Scynexis is operating at the current time. Most of Scynexis' value examination focuses on studying past and present price action to predict the probability of Scynexis' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Scynexis' price. Additionally, you may evaluate how the addition of Scynexis to your portfolios can decrease your overall portfolio volatility.